Insights
Hear Directly From Our Experts
Leadership That Transformed Quality : A Journey From Compliance to Confidence
April 8, 2026 | by Team Vertentis
Regulatory trends Leadership That Transformed Quality : A Journey From Compliance to Confidence the story The Situation When Vertentis first...
Continue Reading →
Why Repeat Observations Are Becoming a Defining Regulatory Signal
April 8, 2026 | by Team Vertentis
Regulatory trends Why Repeat Observations Are Becoming a Defining Regulatory Signal Regulatory enforcement is rarely about a single observation.Increasingly, it...
Continue Reading →
FDA FY2025 Report on the State of Pharmaceutical Quality
April 8, 2026 | by Team Vertentis
Regulatory trends What Today’s Regulatory Signals Are Really Telling Industry The FY2024 Report on the State of Pharmaceutical Quality presents a picture...
Continue Reading →
What Today’s Regulatory Signals Are Really Telling Industry
April 8, 2026 | by Team Vertentis
Regulatory trends What Today’s Regulatory Signals Are Really Telling Industry Regulatory expectations in life sciences are not changing through sudden...
Continue Reading →
Inspection Readiness Is a System, Not an Event
April 8, 2026 | by Team Vertentis
QUALITY IN PRACTICE Inspection Readiness Is a System, Not an Event Many organizations treat inspection readiness as a milestone, something...
Continue Reading →
Quality Lives Here: Building Quality Systems That Endure
April 6, 2026 | by Team Vertentis
Regulatory trends Quality Lives Here: Building Quality Systems That Endure More than half of FDA inspection observations cite systemic quality issues, often...
Continue Reading →